By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
  • Podcast & Media
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • GMJ Briefs
  • Read the Journal →
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
  • Podcast & Media
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • GMJ Briefs
  • Read the Journal →
Follow US
GMJ News > Policy & Systems > Quality & Safety > FDA Issues Class I Recall for VOCSN V+Pro Ventilators Over Critical Oxygen Leak Risk
Policy & SystemsQuality & Safety

FDA Issues Class I Recall for VOCSN V+Pro Ventilators Over Critical Oxygen Leak Risk

GMJ
Last updated: 05/24/2026 22:53
By
GMJ News Desk
Share
6 Min Read
FDA Class I recall notice for VOCSN V+Pro ventilators showing medical device safety alert
FDA announces Class I recall of VOCSN V+Pro ventilators due to manufacturing defect causing undetected oxygen leaks. React Health removes affected devices that pose life-threatening risks to patients. — Photo: www.kaboompics.com / Pexels
SHARE

The U.S. Food and Drug Administration has announced a Class I recall of VOCSN V+Pro ventilators manufactured by React Health, citing a critical manufacturing defect that could cause undetected oxygen leaks and potentially life-threatening complications for patients requiring respiratory support.

Contents
      • FDA Medical Device Recall Classifications
  • Critical Manufacturing Defect Identified
  • Patient Safety Implications
  • Healthcare Provider Response
    • Key takeaways
  • Frequently asked questions
    • What makes this a Class I recall?
    • How can healthcare facilities identify affected devices?
    • What should patients using these ventilators do?
Class I
Most serious FDA recall classification for devices that may cause serious injury or death

FDA Medical Device Recall Classifications

Recall severity levels by potential health impact, 2024

Class I (Most Serious)

Life-threatening risk

Class II (Moderate)
75% of recalls
Class III (Minor)
25% of recalls

Source: FDA Medical Device Safety, 2024 | Georgian Medical Journal News

Critical Manufacturing Defect Identified

The recall affects VOCSN V+Pro ventilators due to a manufacturing process deviation that may result in an undetected oxygen leak condition, according to the FDA safety alert. React Health initiated the voluntary removal of affected devices from the market after identifying the critical safety issue.

Submit Your Paper
GMJ_Submit_Banner

The oxygen leak condition poses significant risks to patients who depend on precise oxygen delivery for respiratory support. Healthcare facilities using these devices have been advised to immediately check their inventory and discontinue use of affected units. For more information on medical device safety protocols, healthcare providers can access additional resources.

Patient Safety Implications

Undetected oxygen leaks in ventilators can lead to inadequate oxygen delivery to critically ill patients, potentially resulting in hypoxemia and respiratory failure. The Centers for Disease Control and Prevention emphasizes that proper ventilator function is essential for patient outcomes in intensive care settings.

Healthcare facilities are required to identify affected devices through serial number verification and implement immediate corrective actions. The recall underscores the importance of robust quality control measures in medical device manufacturing.

Healthcare Provider Response

React Health has notified healthcare customers directly about the recall and provided detailed instructions for device identification and replacement procedures. The company is working with the FDA’s Center for Devices and Radiological Health to ensure comprehensive resolution of the safety issue.

Medical facilities using VOCSN V+Pro ventilators should contact React Health immediately for device verification and replacement options. The recall reflects ongoing efforts to maintain the highest standards of patient safety in critical care environments.

Manufacturing process deviation may result in undetected oxygen leak condition that poses life-threatening risks to ventilator-dependent patients

— FDA Center for Devices and Radiological Health (FDA Safety Alert, 2024)

Key takeaways

  • Class I recall issued for VOCSN V+Pro ventilators due to critical oxygen leak risk
  • Manufacturing defect may cause undetected oxygen delivery failures
  • Healthcare facilities must immediately verify and discontinue use of affected devices
  • React Health providing direct customer notification and replacement procedures

Frequently asked questions

What makes this a Class I recall?

Class I is the most serious FDA recall classification, reserved for devices that may cause serious injury or death. The oxygen leak condition in these ventilators poses life-threatening risks to patients requiring respiratory support.

How can healthcare facilities identify affected devices?

Healthcare providers should check device serial numbers against the recall notice and contact React Health directly for verification. The company has provided specific identification procedures in their customer notifications.

What should patients using these ventilators do?

Patients should not attempt to stop using their ventilators independently. Healthcare providers and home care companies will handle device verification and replacement procedures to ensure continuous respiratory support.

The VOCSN V+Pro recall highlights the critical importance of manufacturing quality control in life-supporting medical devices. Healthcare systems must maintain vigilant monitoring of device recalls and implement rapid response protocols to protect patient safety. This incident reinforces the need for robust regulatory oversight and manufacturer accountability in the medical device industry.

Source: Ventilator Recall: React Health Removes VOCSN V+Pro Ventilators


TAGGED:FDA Class I recallmedical device safetyoxygen leakReact Healthventilator recall
Share This Article
Facebook Copy Link Print
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
US Travel Restrictions on Ebola-Exposed Regions Draw Human Rights Concerns

US travel restrictions on travelers from Ebola-affected regions in Central Africa are…

Healthcare Systems Must Prioritize Human Connection to Combat Employee Burnout Crisis

Healthcare workers face unprecedented burnout rates of 76%, driven by digital systems…

WHO Declares Ebola Outbreak in DRC and Uganda a Global Health Emergency

WHO declares Ebola outbreak in DRC and Uganda a global health emergency…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

WHO health emergency response briefing room with epidemiologists reviewing outbreak data on screens
Global Health

WHO: Ebola outbreak in DRC and Uganda poses high regional risk but no global pandemic emergency

By
GMJ News Desk
Map showing Ebola outbreak spread in eastern Democratic Republic of Congo conflict zones
Global HealthPolicy & Systems

Ebola outbreak spreads to rebel-controlled areas in eastern DR Congo

By
GMJ News Desk
World map showing distribution of high consequence infectious disease risk by country
Global Health

UK Health Agency Identifies 47 Countries with High-Risk Infectious Disease Threats

By
GMJ News Desk
Chart showing rising trend of WHO-detected health emergency events from 2015 to 2024
Global Health

World ‘Moving Backwards’ on Pandemic Preparedness as Disease Outbreaks Surge, GPMB Warns

By
GMJ News Desk
GMJ News > Policy & Systems > Quality & Safety > FDA Issues Class I Recall for VOCSN V+Pro Ventilators Over Critical Oxygen Leak Risk
Uncategorized

FDA Issues Class I Recall for VOCSN V+Pro Ventilators Over Critical Oxygen Leak Risk

Last updated: 05/22/2026 03:28
By
Share
6 Min Read
SHARE

The U.S. Food and Drug Administration has announced a Class I recall of VOCSN V+Pro ventilators manufactured by React Health, citing a critical manufacturing defect that could cause undetected oxygen leaks and potentially life-threatening complications for patients requiring respiratory support.

Contents
      • FDA Medical Device Recall Classifications
  • Critical Manufacturing Defect Identified
  • Patient Safety Implications
  • Healthcare Provider Response
    • Key takeaways
  • Frequently asked questions
    • What makes this a Class I recall?
    • How can healthcare facilities identify affected devices?
    • What should patients using these ventilators do?
Class I
Most serious FDA recall classification for devices that may cause serious injury or death

FDA Medical Device Recall Classifications

Recall severity levels by potential health impact, 2024

Class I (Most Serious)

Life-threatening risk

Class II (Moderate)
75% of recalls
Class III (Minor)
25% of recalls

Source: FDA Medical Device Safety, 2024 | Georgian Medical Journal News

Critical Manufacturing Defect Identified

The recall affects VOCSN V+Pro ventilators due to a manufacturing process deviation that may result in an undetected oxygen leak condition, according to the FDA safety alert. React Health initiated the voluntary removal of affected devices from the market after identifying the critical safety issue.

Submit Your Paper
GMJ_Submit_Banner

The oxygen leak condition poses significant risks to patients who depend on precise oxygen delivery for respiratory support. Healthcare facilities using these devices have been advised to immediately check their inventory and discontinue use of affected units. For more information on medical device safety protocols, healthcare providers can access additional resources.

Patient Safety Implications

Undetected oxygen leaks in ventilators can lead to inadequate oxygen delivery to critically ill patients, potentially resulting in hypoxemia and respiratory failure. The Centers for Disease Control and Prevention emphasizes that proper ventilator function is essential for patient outcomes in intensive care settings.

Healthcare facilities are required to identify affected devices through serial number verification and implement immediate corrective actions. The recall underscores the importance of robust quality control measures in medical device manufacturing.

Healthcare Provider Response

React Health has notified healthcare customers directly about the recall and provided detailed instructions for device identification and replacement procedures. The company is working with the FDA’s Center for Devices and Radiological Health to ensure comprehensive resolution of the safety issue.

Medical facilities using VOCSN V+Pro ventilators should contact React Health immediately for device verification and replacement options. The recall reflects ongoing efforts to maintain the highest standards of patient safety in critical care environments.

Manufacturing process deviation may result in undetected oxygen leak condition that poses life-threatening risks to ventilator-dependent patients

— FDA Center for Devices and Radiological Health (FDA Safety Alert, 2024)

Key takeaways

  • Class I recall issued for VOCSN V+Pro ventilators due to critical oxygen leak risk
  • Manufacturing defect may cause undetected oxygen delivery failures
  • Healthcare facilities must immediately verify and discontinue use of affected devices
  • React Health providing direct customer notification and replacement procedures

Frequently asked questions

What makes this a Class I recall?

Class I is the most serious FDA recall classification, reserved for devices that may cause serious injury or death. The oxygen leak condition in these ventilators poses life-threatening risks to patients requiring respiratory support.

How can healthcare facilities identify affected devices?

Healthcare providers should check device serial numbers against the recall notice and contact React Health directly for verification. The company has provided specific identification procedures in their customer notifications.

What should patients using these ventilators do?

Patients should not attempt to stop using their ventilators independently. Healthcare providers and home care companies will handle device verification and replacement procedures to ensure continuous respiratory support.

The VOCSN V+Pro recall highlights the critical importance of manufacturing quality control in life-supporting medical devices. Healthcare systems must maintain vigilant monitoring of device recalls and implement rapid response protocols to protect patient safety. This incident reinforces the need for robust regulatory oversight and manufacturer accountability in the medical device industry.

Source: Ventilator Recall: React Health Removes VOCSN V+Pro Ventilators

{“@context”:”https://schema.org”,”@type”:”NewsArticle”,”headline”:”FDA Issues Class I Recall for VOCSN V+Pro Ventilators Over Critical Oxygen Leak Risk”,”description”:”FDA Class I recall: VOCSN V+Pro ventilators removed due to critical oxygen leak defect. React Health addresses manufacturing issue affecting patient safety.”,”author”:{“@type”:”Organization”,”name”:”GMJ Editorial Team”},”publisher”:{“@type”:”Organization”,”name”:”GMJ News — Georgian Medical Journal”},”datePublished”:”2026-05-22″,”dateModified”:”2026-05-22″}
{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What makes this a Class I recall?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Class I is the most serious FDA recall classification, reserved for devices that may cause serious injury or death. The oxygen leak condition in these ventilators poses life-threatening risks to patients requiring respiratory support.”}},{“@type”:”Question”,”name”:”How can healthcare facilities identify affected devices?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Healthcare providers should check device serial numbers against the recall notice and contact React Health directly for verification. The company has provided specific identification procedures in their customer notifications.”}},{“@type”:”Question”,”name”:”What should patients using these ventilators do?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Patients should not attempt to stop using their ventilators independently. Healthcare providers and home care companies will handle device verification and replacement procedures to ensure continuous respiratory support.”}}]}

TAGGED:FDA Class I recallmedical device safetyoxygen leakReact Healthventilator recall
Share This Article
Facebook Copy Link Print
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Air France Flight Diverts to Canada After Passenger From Ebola-Hit Congo Boards ‘In Error’

Air France flight from Paris to Detroit diverted to Montreal after passenger…

South Carolina Measles Outbreaks Linked to Childhood Undervaccination Clusters

New research reveals that 73% of measles cases in South Carolina occurred…

Andes Hantavirus Outbreak Infects 15 on Antarctic Cruise Ship

Fifteen people contracted Andes hantavirus during an Antarctic cruise, marking the first…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

FDA medical device alert notice for TRUE METRIX blood glucose monitor
Clinical Updates

FDA Issues Correction Notice for TRUE METRIX Blood Glucose Monitors Over Error Code Risk

By
GMJ News Desk
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

[mc4wp_form]

Join Community
Made by ThemeRuby using the Foxiz theme. Powered by WordPress
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up